Sequential Therapies in Metastatic Renal Cell Carcinoma: Option or Strategy?

被引:5
作者
Bracarda, Sergio [1 ]
De Simone, Valeria [1 ]
机构
[1] Osped S Maria Misericordia, Dept Med Oncol, I-06156 Perugia, Italy
关键词
D O I
10.1016/j.eururo.2008.08.066
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1219 / 1220
页数:2
相关论文
共 8 条
[1]  
[Anonymous], COCHRANE DATABASE SY
[2]  
Dham A, 2007, J CLIN ONCOL, V25
[3]   Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis [J].
Eichelberg, Christian ;
Heuer, Roman ;
Chun, Felix K. ;
Hinrichs, Kristin ;
Zacharias, Mario ;
Huland, Hartwig ;
Heinzer, Hans .
EUROPEAN UROLOGY, 2008, 54 (06) :1373-1378
[4]   Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial [J].
Motzer, Robert J. ;
Escudier, Bernard ;
Oudard, Stephane ;
Hutson, Thomas E. ;
Porta, Camillo ;
Bracarda, Sergio ;
Gruenwald, Viktor ;
Thompson, John A. ;
Figlin, Robert A. ;
Hollaender, Norbert ;
Urbanowitz, Gladys ;
Berg, William J. ;
Kay, Andrea ;
Lebwohl, David ;
Ravaud, Alain .
LANCET, 2008, 372 (9637) :449-456
[5]   Update on the medical treatment of metastatic renal cell carcinoma [J].
Ravaud, Alain ;
Wallerand, Herve ;
Culine, Stephane ;
Bernhard, Jean-Christophe ;
Fergelot, Patricia ;
Bensalah, Karim ;
Patard, Jean-Jacques .
EUROPEAN UROLOGY, 2008, 54 (02) :315-325
[6]   Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma [J].
Rini, BI ;
Small, EJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (05) :1028-1043
[7]  
Sablin MP, 2007, J CLIN ONCOL, V25
[8]   Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy [J].
Tamaskar, Ila ;
Garcia, Jorge A. ;
Elson, Paul ;
Wood, Laura ;
Mekhail, Tarek ;
Dreicer, Robert ;
Rini, Brian I. ;
Bukowski, Ronald M. .
JOURNAL OF UROLOGY, 2008, 179 (01) :81-86